72
Participants
Start Date
January 31, 2013
Primary Completion Date
June 30, 2013
Study Completion Date
June 30, 2013
Fp MDPI
"Fp MDPI is an inhalation-driven multidose dry powder inhaler (MDPI) containing fluticasone propionate dispersed in a lactose monohydrate excipient and contained within a reservoir. A metered dose of drug is delivered to a dose cup via an air pulse activated when the cap is opened.~Fp at 100 mcg was an active comparator (single dose). Further, participants were instructed to administer two inhalations of Fp MDPI 50 mcg twice daily (100 mcg total dose) during the Run-in (to replace the participant's current inhaled corticosteroid) and Washout Periods between treatments."
FS MDPI
FS MDPI is an inhalation-driven multidose dry powder inhaler (MDPI) containing fluticasone propionate and salmeterol xinafoate dispersed in a lactose monohydrate excipient and contained within a reservoir. A metered dose of drug is delivered to a dose cup via an air pulse activated when the cap is opened. The fluticasone propionate component was a fixed dose of 100 mcg. The salmeterol xinofoate dosage varied: 6.25, 12.5, 25 or 50 mcg.
Advair Diskus
ADVAIR DISKUS (100/50 mcg fluticasone propionate/salmeterol xinafoate) consists of a dry powder formulation of fluticasone propionate and salmeterol xinafoate in a lactose excipient. The dry powder is contained within individual blisters on a double foil strip within the device. Activation of the device opens a single blister of medication which is then dispersed into the air-stream by patient inhalation.
Albuterol
Albuterol (Pro-Air) hydrofluoroalkane (HFA) metered dose inhaler (MDI), was provided to be used as needed for the relief of asthma symptoms during both the run-in and treatment periods (to replace the subject's current rescue medication).
Teva Investigational Site 10453, Denver
Teva Investigational Site 10452, North Dartmouth
Teva Investigational Site 10455, St Louis
Teva Investigational Site 10454, Skillman
Teva Investigational Site 10448, Raleigh
Teva Investigational Site 10451, Medford
Teva Investigational Site 10449, Portland
Teva Investigational Site 10457, El Paso
Teva Investigational Site 10450, New Braunfels
Teva Investigational Site 10456, San Antonio
Teva Branded Pharmaceutical Products R&D, Inc.
INDUSTRY